Marek Ciszewski | Director, IR |
Panna Sharma | President and CEO |
David Margrave | CFO |
Kyle Bauser | Colliers Securities |
Daniel Carlson | TW Research Group |
John Vandermosten | Zacks Small Cap |
Good afternoon and welcome to Lantern Pharma’s Fourth Quarter 2020 Conference Call.
As a reminder, this call is being recorded and all participants are in listen-only mode.
We will open the call for questions-and-answers after the presentation. I would now like to introduce your host for today's conference, Marek Ciszewski with Investor Relations at Lantern Pharma. Marek, please go ahead.